“…With an increasing population of adults who are seronegative for anti-HAV antibodies, vaccination is becoming increasingly important. Vaccination in children could provide protection into adulthood [ 53 ]; however, it is also important to consider broadening HAV vaccination coverage in adult populations, particularly for at-risk groups such as HCPs.…”